Gabexate mesylate - CAS 56974-61-9
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
Molecular Weight:
Factor Xa | Ser/Thr Protease
Gabexate is a serine protease inhibitor that inhibits trypsin (IC50= 9.4μM), plasmin (IC50= 30μM), plasma kallikrein (IC50= 41μM) and thrombin (IC50= 110μM). It is used therapeutically (as gabexate mesilate) in the treatment of pancreatitis, disseminated intravascular coagulation, and as a regional anticoagulant for haemodialysis.
Solid powder
4-[[6-[(Aminoiminomethyl)amino]-1-oxohexyl]oxy]-benzoic acid ethyl ester mesylate; Gabexate; Gabexate mesylate; gabexate mesilate. Arodate; Megacart; Megacert; Mesyl Gabexate; Arodate.
Store in a cool and dry place (or refer to the Certificate of Analysis).
Canonical SMILES:
1.A novel thermosensitive in-situ gel of gabexate mesilate for treatment of traumatic pancreatitis: An experimental study.
Gao HJ1,2, Song Q3, Lv FQ4, Wang S5, Wang YR4, Luo YK4, Mei XG5, Tang J6. J Huazhong Univ Sci Technolog Med Sci. 2015 Oct;35(5):707-11. doi: 10.1007/s11596-015-1494-2. Epub 2015 Oct 22.
Gabexate mesilate (GM) is a trypsin inhibitor, and mainly used for treatment of various acute pancreatitis, including traumatic pancreatitis (TP), edematous pancreatitis, and acute necrotizing pancreatitis. However, due to the characteristics of pharmacokinetics, the clinical application of GM still needs frequently intravenous administration to keep the blood drug concentration, which is difficult to manage. Specially, when the blood supply of pancreas is directly damaged, intravenous administration is difficult to exert the optimum therapy effect. To address it, a novel thermosensitive in-situ gel of gabexate mesilate (GMTI) was developed, and the optimum formulation of GMTI containing 20.6% (w/w) P-407 and 5.79% (w/w) P188 with different concentrations of GM was used as a gelling solvent. The effective drug concentration on trypsin inhibition was examined after treatment with different concentrations of GMTI in vitro, and GM served as a positive control.
2.Effect of Somatostatin, Ulinastatin and Gabexate on the Treatment of Severe Acute Pancreatitis.
Wang G1, Liu Y2, Zhou SF3, Qiu P4, Xu L4, Wen P4, Wen J4, Xiao X5. Am J Med Sci. 2016 May;351(5):506-12. doi: 10.1016/j.amjms.2016.03.013. Epub 2016 Mar 31.
OBJECTIVE: The objective of this study is to evaluate the efficacy of somatostatin, ulinastatin and gabexate for the treatment of severe acute pancreatitis.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Factor Xa Products

CAS 256476-36-5 UK-371804 HCl

UK-371804 HCl
(CAS: 256476-36-5)

UK-371804 is a potent and selective urokinase-type plasmogen activator (uPA) inhibitor. Study in vitro showed that it inhibited exogenous uPA in human chronic w...

CAS 56974-61-9 Gabexate mesylate

Gabexate mesylate
(CAS: 56974-61-9)

Gabexate is a serine protease inhibitor that inhibits trypsin (IC50= 9.4μM), plasmin (IC50= 30μM), plasma kallikrein (IC50= 41μM) and thrombin (IC50= 110μM). It...

CAS 114870-03-0 Fondaparinux sodium

Fondaparinux sodium
(CAS: 114870-03-0)

Fondaparinux sodium is a factor Xa inhibitor that mediates the interaction of herparin with antithrombins. It is used for the prevention of venous thromboemboli...

CAS 1346547-00-9 GSK583

(CAS: 1346547-00-9)

GSK583 is a selective receptor-interacting serine/threonine-protein kinase 2 (RIP2 Kinase) inhibitor and the RIP2K binding IC50 is 5 nM. GSK583 can inhibit both...

CAS 24365-47-7 Leupeptin

(CAS: 24365-47-7)

Leupeptin reversibly inhibits serine proteinases (trypsin (Ki=3.5 nM), plasmin (Ki= 3.4 nM), porcine kallikrein), and cysteine proteinases (papain, cathepsin B ...

CAS 480449-70-5 Edoxaban

(CAS: 480449-70-5)

Edoxaban is an oral factor Xa (FXa) inhibitor, also contraindicated in patients with active pathological bleeding.

CAS 81525-10-2 Nafamostat

(CAS: 81525-10-2)

Nafamostat is a broad spectrum serine protease inhibitor and kallikrein inhibitor. It inhibits blood coagulation and used as an anticoagulant. It is also a poss...

CAS 288079-93-6 BMS-344577

(CAS: 288079-93-6)

BMS-344577 is aroylguanidine-based lactam derivative, which is a potent FXa inhibitor (FXa IC(50)=4 nM, EC(2xPT)=7 microM).

Chemical Structure

CAS 56974-61-9 Gabexate mesylate

Quick Inquiry

Verification code

Featured Items